1. Home
  2. Browse Decisions
  3. F.3d
  4. 786 F.3d
  5. 786 F.3d 892 (2015)
 

CLASSEN IMMUNOTHERAPIES v. ELAN PHARMACEUTICALS

No. 2014-1671.

786 F.3d 892 (2015)

CLASSEN IMMUNOTHERAPIES, INC., a Maryland Corporation, Plaintiff-Appellant John Barthelow Classen, Counterclaim Defendant v. ELAN PHARMACEUTICALS, INC., a Delaware Corporation, Defendant/Counterclaimant-Appellee.

United States Court of Appeals, Federal Circuit.

May 13, 2015.

Attorney(s) appearing for the Case

Joseph J. Zito,   DNL Zito, Washington, DC, argued for plaintiff-appellant.

James B. Monroe, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for defendant/counterclaimant-appellee. Also represented by Paul William Browning.

Before PROST, Chief Judge, LOURIE, Circuit Judge, and GILSTRAP, District Judge.

Classen Immunotherapies, Inc. ("Classen") appeals from the decision of the United States District Court for the District of Maryland granting summary judgment that Elan Pharmaceuticals, Inc. ("Elan") did not infringe U.S. Patent 6,584,472 ("the '472 patent") based on the safe harbor provision of 35 U.S.C. § 271(e)(1)...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases